Navigation Links
Onyx Pharmaceuticals to Present at Wachovia Healthcare Conference
Date:1/25/2008

EMERYVILLE, Calif., Jan. 25 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Wachovia Healthcare Conference on Wednesday, January 30, at 8:30 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at:

http://www.wsw.com/webcast/wa48/onxx/

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through March 1, 2008.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. Nexavar is currently approved for the treatment of advanced kidney cancer and for the treatment of liver cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung, melanoma and breast cancers. For more information about Onyx, visit the company's website at: http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...re-FirstCall/ - Medicago Inc. (TSX-V: MDG), a biot...ective and affordable vaccines based on proprietar...les (VLPs), today announced that it has received a... (H1N1) that has recently been identified in USA a...its VLP vaccine technology to produce material for...
...osis, Locations, and Research Benefit Regional Can...ealth System ( www.ochsner.org ) and LSU Health...) have announced a partnership to better serve the...re and cancer research in order to advance patient...re. This collaboration will also further the devel...
...cro IVF, also referred to as ,Mini IVF, or ,Minima...NGELES, April 28 Several esteemed reproductive en...ies.com on the subject of the new "Micro IVF," a..." FertilityTies is the only comprehensive online c...port on fertility matters, connecting members with...
Other Biology Technology:Medicago initiates work on Swine Flu strain 2Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care 2Under the Microscope: 'Micro IVF' 2Under the Microscope: 'Micro IVF' 3
(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
Breaking Biology News(10 mins):Stem cells battle for space 2How to read brain activity? 2Papillomavirus silences innate immune response 2American Mothers Seriously Concerned About Childhood Allergies Siemens Survey Reveals 13087 1American Mothers Seriously Concerned About Childhood Allergies Siemens Survey Reveals 13087 2American Mothers Seriously Concerned About Childhood Allergies Siemens Survey Reveals 13087 3American Mothers Seriously Concerned About Childhood Allergies Siemens Survey Reveals 13087 4American Mothers Seriously Concerned About Childhood Allergies Siemens Survey Reveals 13087 5Cornerstone Therapeutics David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal 52103 1Cornerstone Therapeutics David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal 52103 2SynergEyes Inc Launches New Hybrid Lens Design for Keratoconus Patients 52100 1SynergEyes Inc Launches New Hybrid Lens Design for Keratoconus Patients 52100 2SynergEyes Inc Launches New Hybrid Lens Design for Keratoconus Patients 52100 3
...at the Picower Institute for Learning and Memory a...nce that they have created a way to see, for the f... single neural circuit in a living animal. , This...ower Professor of Biology and Neuroscience, and co...ng circuit in the brain affected learning and memo...
...t cycles that influence the natural world are regu...al is overlooked, balance sheets become inaccurate...ur ability to understand and manage ecological sys...al (Canada) and the Cary Institute of Ecosystem St...ant, but seldom accounted for, withdrawal in the g...
...that identifies regions of the human genome that r...about and develop treatments for a number of human...tute for Genome Sciences & Policy (IGSP). , The m...ly structured, said Gregory Crawford, Ph.D., a res...ators on this study. Our goal was to identify the ...
Other Biology News:New MIT tool probes brain circuits 2When accounting for the global nitrogen budget, don't forget fish 2Search for the 'on' switches may reveal genetic role in development and disease 2
Custom Production Service - Purification from AbD Serotec
Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG
Rat Big Endothelin-1 (Big ET-1) EIA Kit from Assay Designs/Stressgen Bioreagents
Goat Anti-Qa-1 (L-12) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: